EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Use of CFTR modulators in special populations, part 1: Pregnancy and lactation

Joseph Elijah iD, Linda J Fitzgerald, Hanna Phan iD

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26706 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Joseph Elijah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Michigan Medicine, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Safety and efficacy data regarding cystic fibrosis transmembrane conductance regulator (CFTR) modulator use in the setting of pregnancy or breastfeeding remains lacking due to exclusion from key trials and lack of multicenter prospective and retrospective studies in the post‐CFTR modulator era. A scoping review of English articles from the period of January 1, 2012, to July 31, 2023, was conducted utilizing PubMed and EmBase databases with the following terms: “special population (pregnancy, lactation, breastfeeding)” AND “ivacaftor OR lumacaftor OR tezacaftor OR elexacaftor”; “cystic fibrosis transmembrane conductance regulator” AND “off label drug use.” Search results were reviewed by title and abstract for duplications and relevance. Relative to pregnancy or breastfeeding, a total of 18 publications were included for review. Majority of case reports and surveys concluded maternal and infant health were preserved throughout gestation. Likewise, breastfeeding infant case reports show possible changes in liver function and lens opacities, though risk may be increased with both in‐utero and breastfeeding exposure. Ivacaftor (IVA) and lumacaftor (LUM) concentrations in fetal cord blood and maternal blood were found to be equivalent. Yet, low concentrations of IVA and LUM were detectable in breastmilk and infant plasma. Current safety data surrounding CFTR modulator use in the setting of pregnancy and lactation is relatively reassuring; however, long‐term safety remains unclear, necessitating ongoing observation, and reporting by care teams. As such, treatment decisions should be individualized and coproduced.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisFemaleHumansPregnancyBreast FeedingRetrospective StudiesOff-Label UseProspective StudiesBenzodioxolesAminophenolsLactationMutationAminopyridinesQuinolones

Stichwörter der Autor:innen

CFTR modulatorsbreastfeedingcystic fibrosislactationpregnancy

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorBenzodioxolesAminophenolslumacaftorAminopyridinesivacaftorQuinolonesCFTR protein, human

Autor:innen und Institutionen

  • Department of Pharmacy Services, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
  • School of Pharmacy and Pharmaceutical Sciences, Bouve College of Health Sciences, Northeastern University, Boston, United States.
  • Sanofi Medical Affairs, Bridgewater, New Jersey, USA.
  • Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Joseph Elijah, Hanna Phan

Förderung

  • None

Zitieren

APA

Elijah, J., Fitzgerald, L. J., & Phan, H. (2023). Use of CFTR modulators in special populations, part 1: Pregnancy and lactation. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26706

Vancouver

Elijah J, Fitzgerald LJ, Phan H. Use of CFTR modulators in special populations, part 1: Pregnancy and lactation. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26706

BibTeX
@article{Elijah2023,
  author = {Elijah, Joseph and Fitzgerald, Linda J and Phan, Hanna},
  title = {Use of CFTR modulators in special populations, part 1: Pregnancy and lactation},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26706}
}
Kostenlos starten →